Watad, A., McGonagle, D., Bragazzi, N. L., Tiosano, S., Comaneshter, D., Shoenfeld, Y., . . . Amital, H. (2019). Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival. Oncoimmunology.

Watad, Abdulla, Dennis McGonagle, Nicola L. Bragazzi, Shmuel Tiosano, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen, and Howard Amital. "Autoantibody Status in Systemic Sclerosis Patients Defines Both Cancer Risk and Survival With ANA Negativity in Cases With Concomitant Cancer Having a Worse Survival." Oncoimmunology 2019.

Watad, Abdulla, et al. "Autoantibody Status in Systemic Sclerosis Patients Defines Both Cancer Risk and Survival With ANA Negativity in Cases With Concomitant Cancer Having a Worse Survival." Oncoimmunology 2019.